One idea for treating disease is to be able to program cells. Now, a major advance in synthetic biology allows for that kind of control that hasn't been seen before. The Institute for Protein Design...
Type: Upload file
Lab activity in Dr. Paul Yager's lab reflects work on paper-based diagnostics. Their hope is that in two to three years, people miles from a lab will be able to cough, spit, or urinate on a piece of...
Maybe one in 9 people – or 15 percent of the people using opioids -- do well long-term because of their pain issue, says Dr. David Tauben, head of the Center for Pain Relief at UW Medicine. Tauben...
(Downloadable video, b-roll of John Scott and cellular images, and broadcast script) Dr. John D. Scott discusses research results reported in the journal Science that overturn long-held views on a...
(Downloadable video and script) Anitha Pasupathy explains her lab's neuroscience work on how the brain functions when trying to recognize fully visible and partially covered shapes. Pasupathy is an...
(Downloadable video soundbites and lab b-roll) Scientist David Baker discusses creating proteins custom tailored to specific therapeutic targets. See related story.
Alzheimer’s is a slow-progressing disease that can be latent for 15 years before developing into cognitive impairment and dementia. And evidence suggests that healthy behaviors can delay the...
Recent studies indicate that infants born prematurely have a higher risk of developing heart disease later in life. Now, researchers at the University of Washington School of Medicine in Seattle have...
Deborah Fuller, a professor in the Department of Microbiology at the University of Washington School of Medicine, talks about her research into creating a universal flu vaccine.
Jesse Fann, professor of psychiatry and behavioral sciences at the University of Washington School of Medicine, is the lead author of a paper in Lancet Psychiatry, "Long-term risk of dementia among...